Cannabiz Australia reports..
An Australian company specialising in delta-8 THC products has responded to the Therapeutic Goods Administration’s firm stand on the cannabinoid, urging it to ‘foster not snuff out’ the medicine.
TGA boss Professor John Skerritt recently used the ACannabis conference to clarify the regulator’s position on delta-8.
And this week’s TGO93 reforms include a clause which appears to prevent delta-8 products from being prescribed in Australia.
Section 8(b) states: “The chemical structure of the active ingredient or other cannabinoid must not be modified or transformed in any way (including by chemical or other means).”
Read full report
Specialist firm urges TGA to rethink position on delta-8 THC
